The KPNA4 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HeLa cells, engineered to eliminate KPNA4 expression. This polyclonal loss-of-function model abolishes the karyopherin alpha 4 adaptor critical for classical NLS-mediated nuclear import, enabling population-level studies of nucleocytoplasmic transport without clonal bias.
HeLa cells are an immortalized human epithelial line from a cervical adenocarcinoma, widely utilized in biomedical research. Retaining HPV-driven oncogenic signaling, including dysregulated p53 and NF-??B pathways, HeLa provides a biologically relevant host for examining KPNA4 function in cervical cancer and viral pathogenesis.
KPNA4 recognizes cargo proteins with classical NLS and forms a tertiary complex with importin beta (KPNB1). Docking at the nuclear pore complex via nucleoporins (NUP50, NUP62), this complex translocates into the nucleus upon RanGTP binding. Upstream regulation by CK2 phosphorylation and cytokines, and downstream nuclear import of transcription factors (NF-??B, AP-1, p53) and cell cycle regulators (cyclins, CDK inhibitors) position KPNA4 at a nexus of signaling networks. Its loss disrupts nuclear entry of these factors, impairing transcriptional responses and cell cycle progression.
In the HeLa cervical cancer context, KPNA4 knockout impedes nuclear translocation of NF-??B and p53, potentially attenuating pro-survival signaling and proliferation. Given the HPV-positive background, KPNA4 disruption may also hinder viral replication dependent on host import machinery. This model thus permits mechanistic inquiry into karyopherin contributions to cervical adenocarcinoma and broader cancer phenotypes.
Applications include western blotting and immunofluorescence to verify protein knockdown, co-immunoprecipitation to probe KPNA4-cargo interactions, and NF-??B luciferase reporter assays to gauge signaling output. Cell proliferation and flow cytometry-based cell cycle assays reveal functional consequences of KPNA4 loss. Virology experiments test nuclear import requirements for pathogens like HIV or influenza, while RNA-seq elucidates global transcriptional changes. For further information, contact Ascent Research.
